Zobrazeno 1 - 10 of 63 pro vyhledávání: '"Mehrad, Adibi"'
1
Akademický článek
Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma
Autor: Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah
Publikováno v: BJUI Compass, Vol 3, Iss 1, Pp 37-44 (2022)
Abstract Objectives Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU).
Externí odkaz: https://doaj.org/article/4bec1710d1984582ada90fc20a09d76b
Zobrazit plný text záznamu
2
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi‐institutional retrospective cohort study
Autor: Kyle M. Rose, Gopal Narang, Geoffrey Rosen, Craig Labatte, Catalina I. Dumitrascu, Justin Campagna, Alice Yu, Brandon J. Manley, Phillippe E. Spiess, Roger Li, Mehrad Adibi, Katie S. Murray, Wade J. Sexton, Mitchell R. Humphreys
Publikováno v: BJU International. 131:471-476
To assess the safety profile of antegrade mitomycin gel instillation through a percutaneous nephrostomy tube (PCNT) for upper tract urothelial carcinoma (UTUC) with the aim of decreasing morbidity associated with therapy.Patients undergoing antegrade
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e22aef140cc54436a0334bd970900f8b
https://doi.org/10.1111/bju.15925
Zobrazit plný text záznamu
8
Akademický článek
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma
Autor: Leonardo D. Borregales, Mehrad Adibi, Arun Z. Thomas, Christopher G. Wood, Jose A. Karam
Publikováno v: Therapeutic Advances in Urology, Vol 8 (2016)
In the past decade, the armamentarium of targeted therapy agents for the treatment of metastatic renal cell carcinoma (RCC) has significantly increased. Improvements in response rates and survival, with more manageable side effects compared with inte
Externí odkaz: https://doaj.org/article/d453898fb8814456ab5565c3d0103f37
Zobrazit plný text záznamu
9
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma
Autor: Craig V. Labbate, Patrick J. Hensley, Tanner S. Miest, Wei Qiao, Mehrad Adibi, Amishi Y. Shah, Lisly Chery, John Papadopoulos, Arlene O. Siefker-Radtke, Jianjun Gao, Charles C. Guo, Bogdan A. Czerniak, Neema Navai, Ashish M. Kamat, Colin P. Dinney, Matthew T. Campbell, Surena F. Matin
Publikováno v: Urologic oncology. 40(10)
Renal function dictates sequencing and eligibility for definitive therapy in upper tract urothelial carcinoma. We investigated longitudinal glomerular filtration rate (GFR) changes after neoadjuvant chemotherapy (NAC) and nephroureterectomy (RNU).Pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c11a897e209078225f5d0c2dfc339ae6
https://pubmed.ncbi.nlm.nih.gov/35961847
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje